CEFALY Technology Presents TEAM Study Findings at the American Headache Society's 2023 Scientific Meeting sessions that can reduce the frequency and intensity of future migraines. Medical device maker CEFALY Technology announced that two post-hoc analyses of the TEAM (a phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine) study were presented as posters at the American Headache Society's 65th Annual Scientific Meeting June 15-18 in Austin, Texas.

This FDA-cleared treatment has been clinically proven to relieve migraine pain. CEFALY works by stimulating and desensitizing the trigeminal nerve, which is the primary pathway for migraine pain. The device has two settings. The 60-minute Acute Treatment is for a current migraine, and the 20-minute Prevent Treatment is for daily sessions that can reduce the frequency and intensity of future migraines.

CEFALY Technology Launches Trade-In Program for Purchasers of the New CEFALY Connected Migraine Treatment Device. The CEFALY Connected is the first Bluetooth-enabled CEFALY device. It syncs with the CeCe Migraine Management app, giving users the ability to track CEFALY sessions and log migraine attacks on their mobile device.

CEFALY Technology Launches Trade-In Program for Purchasers of the New CEFALY Connected Migraine Treatment Device. The CEFALY Connected is the first Bluetooth-enabled CEFALY device. It syncs with the CeCe Migraine Management app, giving users the ability to track CEFALY sessions and log migraine attacks on their mobile device.

Medical device maker CEFALY Technology today unveiled the newest evolution of its FDA-cleared migraine treatment device: the CEFALY Connected. Representing a huge leap forward in drug-free migraine treatment technology, the Bluetooth-enabled CEFALY Connected syncs with the CeCe Migraine Management app, allowing users to track CEFALY treatments and log migraine attacks on their mobile devices.

CEFALY Announces Complimentary Coaching Service to Help Users Achieve Success with Their Migraine Treatment. CEFALY Technology has launched a new service: personalized, one-on-one coaching sessions that help users use their CEFALY device to achieve maximum migraine relief.

CEFALY Technology has partnered with Ordergroove, the leader in Relationship Commerce, to offer an upgraded electrode subscription experience to its customers. CEFALY is an FDA-cleared, clinically proven external trigeminal nerve stimulation (e-TNS) device worn on the forehead...

Self-administered external trigeminal nerve stimulation (E-TNS) that is available over the counter is superior to sham stimulation in relieving pain for patients with episodic migraine, results from a phase 3 study show.

I know now I need to take appropriate steps to ward off a full-blown attack. When my neck pain starts, I usually turn to my Cefaly device, often try to make an appointment with my chiropractor, and, too, regularly see my physical therapist...

If you get migraines, you know the debilitating affect they have on your day. "A migraine is more than just a headache," says Alex Feoktistov, M.D., Ph.D., director of the Synergy Integrative Headache Center in Northfield, Illinois.

Anyone who has ever had migraine can tell you how it differs from a severe headache. Migraine can come with a sensitivity to light, sensitivity to sound, and nausea. When it hits, the simplest task or function can become impossible.

Cefaly recently rolled out its latest version of an External Trigeminal Nerve Stimulation device. The company’s device sends tiny electrical impulses through a self-adhesive electrode placed on the forehead to stimulate the trigeminal nerve, which is where migraines start.

Worn on the forehead, CEFALY is a drug-free, external trigeminal nerve stimulation (e-TNS) device approved for both acute and preventive treatment of Migraine.

CEFALY Technology (CEFALY) today announced the introduction of its upgrade program, allowing customers to trade in their existing device for a credit towards its newest device, the CEFALY DUAL Enhanced. Additionally, they extended their return policy from 60 to 90 days.

CEFALY named in Business Worldwide Magazine's List of Most Innovative Companies to Watch The list is a celebration of the trailblazing organizations that are changing the game in their respective industries and altering the corporate landscape. Whether it's healthcare, banking, industry, construction, energy, and more; these companies are at the cutting edge of breakthrough technologies, innovation and modernized business structures.

CEFALY Technology is proud to announce that our new CeCe Migraine Management App has received the 2021 Distinction Award for Best Native Mobile App from eHealthcare! The CeCe migraine management app, launched in May 2021, was developed by CEFALY as a free tool to help those with migraine meet life head on. CeCe provides a simple, intuitive way for anyone with migraine to track triggers, symptoms, and treatments.